Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical batroxase vs dexamethasone during tympanoplasty to prevent middle-ear adhesion
ChiCTR2100043282Phase 4Recruiting
- Sponsor
- Xijing Hospital
- Start
- Feb 2021
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of batroxase in chronic otitis media (COM) and Cholesteatoma (2 arms), sponsored by Xijing Hospital. Primary endpoints: tympanic cavity adhesion, tympanic membrane healed and 1 more. Started Feb 2021; status: recruiting.
02
Drugs
batroxase
03
Conditions
chronic otitis media (COM)Cholesteatoma
Beyond the preview
Go deeper on ChiCTR2100043282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043282.